跳至主要内容
临床试验/EUCTR2006-003284-31-DE
EUCTR2006-003284-31-DE进行中(未招募)不适用

An open label multi-center trial of oseltamivir for the seasonal prophylaxis of influenza in children

F.Hoffmann-La Roche Ltd.0 个研究点目标入组 50 人开始时间: 2006年11月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Males or females 1 to 12 years of age; females must be pre-menarchal
  • Subject is a candidate for seasonal prophylaxis in the opinion of the Principal
  • investigator
  • Negative rapid diagnostic test for influenza at baseline
  • Parent/guardian willing and able to comply with study requirements and give consent
  • Subject able to comply with study requirements and willing to give assent, as
  • appropriate
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Symptoms suggestive of influenza-like illness, including but not limited to, fever,
  • cough, or nasal congestion
  • Positive rapid diagnostic test for influenza
  • Creatinine clearance < 30 ml/min/1.73M2
  • Females of child-bearing potential
  • Uncontrolled renal, vascular, neurologic, metabolic, or pulmonary disease or known chronic renal failure, hepatitis or cirrhosis. Uncontrolled is defined as disease requiring change of therapy or hospitalization within 4 weeks preceding the first dose of study medication. Change of therapy is defined as dose increase or change of medication.
  • Allergy to the test medication
  • Hereditary fructose intolerance (for subjects who will be taking the liquid formulation)
  • Malignancy at the time of enrollment excluding adequately treated skin carcinoma (basal or squamous cell)
  • Participation in a clinical trial with an investigational drug in the 4 weeks prior to
  • enrollment. Patients enrolled in this study can not be enrolled in another study
  • for either research, diagnostic or treatment purposes.
  • Antiviral treatment (example: amantadine, rimantadine, zanamavir, oseltamivir
  • and ribavirin) for influenza in the 2 weeks prior to enrollment.
  • Use of live influenza vaccine (example FluMist) in the 2 weeks prior to enrollment.

研究者

相似试验

进行中(未招募)
不适用
An open label multi-center trial of oseltamivir for the seasonal prophylaxis of influenza in childreSeasonal prophylaxis of influenza in immunocompromised subjectsMedDRA version: 8.1Level: LLTClassification code 10022000Term: Influenza
EUCTR2006-003284-31-DKF.Hoffmann-La Roche Ltd.50
进行中(未招募)
1 期
A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu StraiInfluenza
EUCTR2016-001008-49-Outside-EU/EEAF. Hoffmann-La Roche AG400
进行中(未招募)
不适用
A study to assess the safety of Oseltamivir administered in the vein for the treatment of flu (Influenza) in patients of at least 13 years of age.
EUCTR2010-020083-38-DKF. Hoffmann-La Roche Ltd200
进行中(未招募)
1 期
A study to assess the safety of Oseltamivir administered in the vein for the treatment of flu (Influenza) in patients of at least 13 years of age.Treatment of Influenza [seasonal or pandemic (H1N1) 2009]MedDRA version: 14.0Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.0Level: LLTClassification code 10022003Term: Influenza B virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.0Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.0Level: LLTClassification code 10022002Term: Influenza A virus infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2010-020083-38-DEF. Hoffmann-La Roche Ltd118
进行中(未招募)
不适用
A study to assess the safety of Oseltamivir administered in the vein for the treatment of flu (Influenza) in patients of at least 13 years of age.Treatment of Influenza [seasonal or pandemic (H1N1) 2009]MedDRA version: 14.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10022003Term: Influenza B virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10022002Term: Influenza A virus infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2010-020083-38-LTF. Hoffmann-La Roche Ltd200
An open label multi-center trial of oseltamivir for... | 临床试验